Contact this trialFirst, we need to learn more about you.
Chemotherapy
Fosciclopirox + Cytarabine for Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Kansas City, Kansas
This trial tests a new drug, fosciclopirox, alone and with cytarabine, in patients with a type of blood cancer that hasn't responded to other treatments. The goal is to see if these drugs can stop cancer growth or kill the cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service